ReviewSpringer seminars in immunopathology2005
The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.
Review in Springer seminars in immunopathology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 84 citations in OpenAlex.
- NK Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations.Transplantation and cellular therapy · 2021Review
- Article
- Immunotherapeutic applications of NK cells.Pharmaceuticals (Basel, Switzerland) · 2015Review
- The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells.Journal of immunology (Baltimore, Md. : 1950) · 2014Article
- Natural killer cells modulation in hematological malignancies.Frontiers in immunology · 2013Article
- Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity.European journal of microbiology & immunology · 2011Review
- Epigenetic patterns associated with the immune dysregulation that accompanies psychosocial distress.Brain, behavior, and immunity · 2011Article
- Bi-specific aptamers mediating tumor cell lysis.The Journal of biological chemistry · 2011Article
- Progress in understanding melanoma propagation.Molecular oncology · 2010Review
- FimH can directly activate human and murine natural killer cells via TLR4.Molecular therapy : the journal of the American Society of Gene Therapy · 2010Article
- Article
- Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.Journal of leukocyte biology · 2009Review
- Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.Journal of virology · 2009Article
- Interleukin-2 immunotherapy action on innate immunity cells in peripheral blood and tumoral tissue of pancreatic adenocarcinoma patients.Langenbeck's archives of surgery · 2009Article
- NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy.Cancer immunology, immunotherapy : CII · 2008Review
- Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer.Brain, behavior, and immunity · 2008Article
- Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.Journal of immunology (Baltimore, Md. : 1950) · 2008Article
- Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.The Journal of clinical investigation · 2008Article
- Possible stimulation of anti-tumor immunity using repeated cold stress: a hypothesis.Infectious agents and cancer · 2007Article
- Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response.Cancer letters · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural killer (NK) cells are the primary effector cells of the innate immune system and have a well-established role in tumor rejection in a variety of spontaneous and induced cancer models. NK cell function is regulated by a complex balance of inhibitory and activating signals that allow them to selectively target and kill cells that display an abnormal pattern of cell surface molecules, while leaving normal healthy cells unharmed. In this review we discuss NK cell function, the role of NK cells in cancer therapies, the emerging concept of bi-directional cross-talk between NK cells and dendritic cells, and the implications of these interactions for tumor immunotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.